Skip to content
OpenCapital
Get started

ENDRA Life Sciences Inc. NDRA Q4 2024 Annual earnings

Reported March 31, 2025 · Before market open

Revenue$211.6K
EPS-$9.40Miss by $5.30
EPS estimate-$4.10

Next report

Aug 13, 2026 (In 2 weeks)
Revenue estimate$100.0K
EPS estimate-$0.84

Versus estimates

Revenue

Q4 2024$211.6K

Diluted EPS

Q1 2026-$1.09Beat by $0.14Q4 2025-$3.26Miss by $2.03Q3 2025-$1.75Beat by $0.20Q2 2025-$1.71Beat by $0.56Q1 2025-$2.59Beat by $1.32
Q4 2024-$9.40Miss by $5.30

Ask the moment ENDRA Life Sciences Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ENDRA Life Sciences Inc. report Q4 2024 earnings?
ENDRA Life Sciences Inc. (NDRA) reported Q4 2024 earnings on March 31, 2025 before market open.
What were ENDRA Life Sciences Inc.'s Q4 2024 revenue and EPS?
ENDRA Life Sciences Inc. reported revenue of $211.6K and eps of $-9.40 for Q4 2024.
Did ENDRA Life Sciences Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-4.10 by $5.30.
Where can I find ENDRA Life Sciences Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001654954-25-003612) directly on SEC EDGAR. The filing index links above go to sec.gov.